Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pirlindole alpha-2a adrenergic receptor small molecule NA drugbank Major Depressive Disorder[MeSHID:D003865]
Hypertensive disease[MeSHID:D006973]
Unipolar Depression[MeSHID:D003866]
Psychological inhibition[MeSHID:D007266]
Headache[MeSHID:D006261]
Patient Care Management[MeSHID:D010346]
Fibromyalgia[MeSHID:D005356]
Genetic Selection[MeSHID:D012641]
Pain Disorder[MeSHID:D013001]
Mental Depression[MeSHID:D003863]
Pain[MeSHID:D010146]
Syndrome[MeSHID:D013577]
NA experimental antagonist
pirlindole 5-hydroxytryptamine receptor 1a small molecule NA drugbank Major Depressive Disorder[MeSHID:D003865]
Hypertensive disease[MeSHID:D006973]
Unipolar Depression[MeSHID:D003866]
Psychological inhibition[MeSHID:D007266]
Headache[MeSHID:D006261]
Patient Care Management[MeSHID:D010346]
Fibromyalgia[MeSHID:D005356]
Genetic Selection[MeSHID:D012641]
Pain Disorder[MeSHID:D013001]
Mental Depression[MeSHID:D003863]
Pain[MeSHID:D010146]
Syndrome[MeSHID:D013577]
NA experimental antagonist
pirlindole amine oxidase [flavin-containing] a small molecule NA drugbank , DGIDB Major Depressive Disorder[MeSHID:D003865]
Hypertensive disease[MeSHID:D006973]
Unipolar Depression[MeSHID:D003866]
Psychological inhibition[MeSHID:D007266]
Headache[MeSHID:D006261]
Patient Care Management[MeSHID:D010346]
Fibromyalgia[MeSHID:D005356]
Genetic Selection[MeSHID:D012641]
Pain Disorder[MeSHID:D013001]
Mental Depression[MeSHID:D003863]
Pain[MeSHID:D010146]
Syndrome[MeSHID:D013577]
4.39 experimental antagonist,inhibitor
click here to return to the previous page